In last trading session, Outlook Therapeutics Inc (NASDAQ:OTLK) saw 62.14 million shares changing hands with its beta currently measuring 0.61. Company’s recent per share price
Outlook Therapeutics Inc (NASDAQ:OTLK) has a beta value of 0.61 and has seen 20.07 million shares traded in the recent trading session. The company, currently
In last trading session, Outlook Therapeutics Inc (NASDAQ:OTLK) saw 0.37 million shares changing hands with its beta currently measuring 0.69. Company’s recent per share price
During the last session, Outlook Therapeutics Inc (NASDAQ:OTLK)’s traded shares were 0.29 million, with the beta value of the company hitting 0.63. At the end
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
